Clinical Trials Browser

Interventional × Triple Negative Breast Neoplasms × Antineoplastic Agents × Clear all

NCT03799679 2019-01-10

Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer

Phase 4 Unknown

Triple Negative Breast Neoplasms